Advanced Oncotherapy (AVO) – Video of LIGHT system and testing facilities

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that a new video is available on the Company’s website providing an inside look at the groundbreaking technical development of the LIGHT system at its testing facility on the CERN campus in Geneva.

The video can be viewed here: www.avoplc.com

Commenting, Nicolas Serandour, CEO of Advanced Oncotherapy, said: “This latest video provides an excellent insight into the considerable technical progress that has been made in developing our first LIGHT system, the importance of our international partners in this collaboration and the critical involvement of CERN’s expertise in applying their knowhow to the treatment of cancers by Proton Beam Therapy. Our development work is making great strides, as demonstrated by the integration of our proton source and Radio Frequency Quadruple (RFQ) and the high power testing of our proprietary modular accelerating units, the Side Coupled Drift Tube Linacs (SCDTL) and Coupled Cavity Linacs (CCL). We will continue to update shareholders with further progress.”

About Advanced Oncotherapy Plc www.avoplc.com

Advanced Oncotherapy is a provider of particle therapy with protons that harnesses the best in modern technology. Advanced Oncotherapy’s team “ADAM”, based in Geneva, focuses on the development of a proprietary proton accelerator called Linac Image Guided Hadron Technology (LIGHT). LIGHT accelerates protons to the energy levels achieved in legacy machines but in a unit that is a quarter of the size and between a quarter and a fifth of the cost. This compact configuration delivers proton beams in a way that facilitates greater precision and electronic control which is not achievable with older technologies.

Advanced Oncotherapy will offer healthcare providers affordable systems that will enable them to treat cancer with an innovative technology as well as better health outcomes and lower treatment related side effects.

Advanced Oncotherapy continually monitors the market for any emerging improvements in delivering proton therapy and actively seeks working relationships with providers of these innovative technologies. Through these relationships, the Company will remain the prime provider of an innovative and cost-effective system for particle therapy with protons.